S Migasena

Safety and Immunogenicity of Different Immunization Regimens of CVD 103-HgR Live Oral Cholera Vaccine in Soldiers and Civilians in Thailand

Pisit Su-Arehawaratana, Preecha Singharaj, David N. Taylor et al. · The Journal of Infectious Diseases · 1992 · 117 citations

Vaccination, Vaccine Safety, Geometric Mean Titer +14

Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3.

D. P. Francis, Timothy J. Gregory, M J McElrath et al. · PubMed · 1998 · 74 citations

Bivalent Formulations, Immunology, Antiviral Drug +18

Phase I/II Study of a Candidate Vaccine Designed Against the B and E Subtypes of HIV-1

Punnee Pitisuttithum, Phillip W. Berman, Benjaluck Phonrat et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2004 · 67 citations

Vaccination, Candidate Vaccine, Phase I/ii Study +14

Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults

S Migasena, P Pitisuttitham, B Prayurahong et al. · Infection and Immunity · 1989 · 57 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +14

Clinical features and diagnosis.

S Migasena, H. M. Gilles, P. A. J. Ball · 1991 · 53 citations

Clinical Disorders, Clinical Finding, Differential Diagnosis +6